A particular type of anemia in humans, called \(\beta\) -thalassemia, results
from a severe reduction or absence of the normal \(\beta\) -globin chain of
hemoglobin. However, the \(\gamma\) -globin chain, normally only expressed
during fetal development, can functionally substitute for \(\beta\) -globin. A
variety of studies have explored the use of the nucleoside 5 -azacytidine for
the expression of \(\gamma\) -globin in adult patients with \(\beta\)
-thalassemia.
(a) How might 5 -azacytidine lead to expression of \(\gamma\) -globin in adult
patients?
(b) Explain why this drug may also have some adverse side effects.